Spring Bank Pharmaceuticals, Inc. (SBPH)


Stock Price Forecast

Nov. 20, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Spring Bank Pharmaceuticals, Inc. chart...

About the Company

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

30

$0M

Total Revenue

30

Employees

$21M

Market Capitalization

-0.74

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SBPH News

Spring Bank Review 2024

1mon ago, source: Business Insider

See how we rate banking products to write unbiased product reviews. The bottom line: Spring Bank could be an excellent choice for New York residents who want to be part of a mission-driven ...

Sandy Spring Bank

6d ago, source: Forbes

Sandy Spring Bancorp, Inc. is the holding company for Sandy Spring Bank, the largest locally-headquartered community bank in the Greater Washington, D.C. region. With over 60 locations ...

SASR Sandy Spring Bancorp, Inc.

4d ago, source: Seeking Alpha

Sandy Spring Bancorp, Inc. operates as the bank holding company for Sandy Spring Bank that provides commercial and retail banking, mortgage, private banking, and trust services to individuals and ...

CRVS Corvus Pharmaceuticals, Inc.

2d ago, source: Seeking Alpha

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers ...

Mira Pharmaceuticals (MIRA) Price Target Increased by 37.58% to 23.15

4mon ago, source: Hosted on MSN

The average one-year price target for Mira Pharmaceuticals (NASDAQ ... What are Other Shareholders Doing? Sandy Spring Bank holds 1K shares representing 0.00% ownership of the company.

Alnylam Pharmaceuticals

6d ago, source: Forbes

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Vertex Pharmaceuticals Inc VRTX

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vanda Pharmaceuticals Inc.

3d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

22d ago, source: Yahoo Finance

April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company ... will host investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 17, 2024 ...

ANI Pharmaceuticals Inc

8d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.

Ionis Pharmaceuticals Inc IONS

1d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...